Ahead of International Pet Day！Hsueh Chao-chi proposes a pet-friendly living zone in Zuoying and Nanzih and development of the pet economy
Published ・ Source Taiwan | 風傳媒
薛兆基, a candidate for city council in Zuoying and Nanzi, unveiled the “Pet-Friendly Living Circle for Zuoying and Nanzi” initiative to mark International Pet Day on August 8. The policy combines animal welfare with the pet economy and aims to revitalize the region.
【Association Affairs Bulletin】Medical Affairs Committee focuses on preventing medical violence and carefully considers measures to protect healthcare workers’ safety on the job
【Association Affairs Bulletin】Association holds second meeting of the Aesthetic Medicine Working Group to improve the quality of aesthetic medicine in Taiwan
【Association Affairs Bulletin】“A New Strategy for a Healthy Taiwan：Early Intervention for the Three Highs and Practical Applications of Family Medicine 2.0” focuses on integrated CKM care and Family Medicine 2.0
【Association Affairs Bulletin】Association holds the 3rd meeting of the 14th Primary Care Committee to discuss billing and review standards for psychiatric treatment items and their implementation in primary care
財團法人藥害救濟基金會 will hold 3 “115 Medical Incident Support Staff Training” sessions。Relevant personnel are invited to register；see the attachment。
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
財團法人藥害救濟基金會 will hold 3 “115 Medical Incident Support Staff Training” sessions in northern，central，and southern Taiwan，with a maximum of 50 participants per session。
中華民國醫師公會全國聯合會 donates 10 million yen to support medical relief，evacuee assistance，and post-disaster reconstruction following the Kumamoto earthquake in Japan
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
To support relief efforts following the Kumamoto earthquake in Japan，中華民國醫師公會全國聯合會 will donate 10 million yen through 日本醫師會 for medical relief in the affected area，assistance for evacuees，and reconstruction。
衛生福利部中央健康保險署 has revised certain provisions of the National Health Insurance Drug Benefit Items and Payment Standards，and changes to covered drugs are as follows：
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
衛生福利部中央健康保險署 has revised the National Health Insurance Drug Benefit Items and Payment Standards。The changes include provisional coverage for 瑩碩’s Xin Qing tablets containing methylphenidate；price changes for 50 drug items；the addition of oxcarbazepine as a special drug and an adjustment to the payment price of Neurtrol F.C. Tablets；and new special import and payment rules for Linezolid Tablets 600mg and Linzid 600mg Tablet。
衛生福利部中央健康保險署 revises the provisions on special materials in the National Health Insurance Drug Payment Items and Payment Standards：
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
衛生福利部中央健康保險署 revises National Health Insurance coverage rules for special materials，temporarily covering products from 柯惠 and 阿爾傑，adding 149 special material items and revising payment standards for ventriculoperitoneal shunt systems。
Notice: 衛生福利部食品藥物管理署 has approved rapid test permits for the novel coronavirus and provided contact information for manufacturers
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
衛生福利部食品藥物管理署 announces approved permits for novel coronavirus rapid tests and contact information for manufacturers，in response to the worsening domestic outbreak and to maintain healthcare and epidemic-prevention capacity。
Notice: 衛生福利部 has sent a letter to local health bureaus regarding strategies and measures in response to the recent worsening of the COVID-19 outbreak
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
衛生福利部，responding to the worsening COVID-19 outbreak，has asked local health bureaus to monitor capacity for critical and emergency care and ensure hospitals implement bed-adjustment mechanisms。The 疾病管制署 will also update outbreak information regularly。
Notice: 疾管署 revises the “Publicly Funded COVID-19 Oral Antiviral Drug Distribution Program”
Published ・ Source Taiwan | 中華民國醫師公會全國聯合會
疾管署 revises the publicly funded COVID-19 oral antiviral drug distribution program，requiring the reason or diagnosis to be recorded when prescribing Molnupiravir and adding related review items to local government health bureaus’ review and guidance。
Big-name investors place their bets！Bill Gates and Bezos join LifeMine’s Series E funding round to develop a new organ-transplant drug，bringing total funding to nearly $560 million - Global Bio & Tech Monthly
Healthy longevity without long-term care！Taipei Medical University’s Senior Health Industry Expo showcases 21 functional foods，dementia care services and senior technology - Global Bio & Tech Monthly
First-half CAR-T sales top $3 billion! 禮來/南京傳奇 maintain their lead, while autoimmune and in vivo CAR-T therapies emerge as the next competitive focus - Global Bio & Investment Monthly
Korea's MFDS launches plan to develop a “Drug AI Review System,” investing 22.3 billion won over three years to improve drug review efficiency - Global Bio & Investment Monthly
Published ・ Source Taiwan | 環球生技月刊
Summary not yet available
Companies mentioned：韓國食品藥物安全處、Ministry of Food and Drug Safety、MFDS
宇斻管顧, 安思創扶 and US-based Larta Institute join forces to establish Larta Asia, connecting startups in Taiwan and the US - Global Bio & Investment Monthly
Published ・ Source Taiwan | 環球生技月刊
Summary not yet available
Facts
Held at Taiwan Tech Arena on July 15
Companies mentioned：宇斻管顧、安思創扶、Larta Institute、Larta Asia
Keynote 3—Yukiko Gotoh: Chromatin mechanisms determine neocortical fate, while the biological clock adds another layer of precise control! - Global Bio & Investment Monthly
Keynote 2—Madeline Lancaster: Developing a self-organizing, brain-targeted choroid plexus to turn the blood-brain barrier into a CNS drug dispatch station! - Global Bio & Investment Monthly
Keynote 1—Shinya Yamanaka: After 20 years, iPSC research is moving into clinical use! The next challenge: making it globally accessible at prices patients can afford - Global Bio & Investment Monthly
Published ・ Source Taiwan | 環球生技月刊
Summary not yet available
Facts
2026 Annual Meeting of 國際幹細胞研究學會
Companies mentioned：國際幹細胞研究學會、International Society for Stem Cell Research
4 years of progress in regenerative medicine for a super-aged society! 7 teams advance to clinical trials and sign 5 MOUs to accelerate industry adoption - Global Bio & Investment Monthly
2026 Senior Health Industry Expo / It's not just about living longer, but enjoying more years in good health! 產發署 showcases new solutions for senior living - Heho Health
Published ・ Source Taiwan | Heho健康
Summary not yet available
Facts
In 2025, the average life expectancy of people in Taiwan reached 80 years
People in Taiwan currently have a healthy life expectancy of only 72 years